Stocksigma LogoStocksigma Logo

CRISIL Upgrades Credit Ratings for Sahajanand Medical Technologies and Subsidiary

CRISIL Ratings has upgraded Sahajanand Medical Technologies Ltd's bank facilities rating to 'CRISIL A-/Stable/CRISIL A2+' from 'CRISIL BBB+/Stable/CRISIL

CRISIL Upgrades Credit Ratings for Sahajanand Medical Technologies and Subsidiary

Sahajanand Medical Technologies Limited 路 Others (Uncategorized) 路 04 Nov 2026, 9:19 pm

CRISIL Upgrades Credit Ratings for Sahajanand Medical Technologies and Subsidiary CRISIL Ratings has upgraded Sahajanand Medical Technologies Ltd's bank facilities rating to 'CRISIL A-/Stable/CRISIL A2+' from 'CRISIL BBB+/Stable/CRISIL A2', enhancing rated limits to Rs 300 crore. Subsidiary SMT Cardiovascular's rating was upgraded to 'CRISIL BBB+/Stable' from 'CRISIL BBB/Stable'. The upgrade reflects a strengthened business risk profile following an 18% YoY operating revenue increase to Rs 1,214.14 crore and a PAT surge to Rs 69.08 crore in FY26, supported by stable operating margins (13.14%) and a healthy capital structure with gearing at 0.43x.

Original exchange filing (PDF)

More announcements from Sahajanand Medical Technologies Limited

All Sahajanand Medical Technologies Limited announcements